ОЦЕНКА ПОКАЗАТЕЛЕЙ МИКРОЦИРКУЛЯТОРНОГО РУСЛА У БОЛЬНЫХ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ, АССОЦИИРОВАНОЙ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ И СУБКЛИНИЧЕСКИМ ГИПОТИРЕОЗОМ

Arterial hypertension (AH) is associated with hypothyroidism, diffuse lesion accelerates the progression of the vascular bed of the great arteries to the capillaries. Objective was to assess the condition of the microcirculation in patients with AH associated with metabolic syndrome (MS) and subclinical hypothyroidism (SH). The study included 75 patients divided into 3 groups: 23 patients with AH, 29 patients with AH in the MS, 23 patients with AH associated with MS and SH. All the patients underwent examination of the state of microcirculation by laser doppler flowmetry. It is established that the presence of even the initial thyroid hypofunction in patients with AH in the MS leads to a decrease in the ability of the physiological modulation of blood flow in the microvasculature.

1. Ефименко Н.А., Чернеховская Н.Е., Федорова Т.А., Шишло В.К. Микроциркуляция и способы ее коррекции. М., 2003. 174 с.

2. Маколкин В.И., Подзолков В.И., Бранько В.В., Самойленко В.В. и др. Микроциркуляция в кардиологии. М.: Визарт, 2004. 135 с.

3. Bindels A.J., Westendorp R.G., Frolich M. et al. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case finding // Clin. Endocrinol. 1999. № 50. Р. 217–20.

4. Floras J.S., Harak K. Sympathoneural and hemodynamic characteristics of young subject with mild essential hypertension // J. Hypertens. 1993. № 11. Р. 647–55.

5. Hak A.E., Pols H.A., Visser T.J. et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study // Ann. Intern. Med. 2000. Vol. 132, № 4. Р. 270–8.

6. Lekakis J., Papamichael C., Alevizaki M. et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and highnormal serum thyrotropin (TSH) values // Thyroid. 1997. Vol. 7, № 3. P. 411–414.

7. Levy B.I., Ambrosio G., Pries A.R. On behalf of the European Working Group for microcirculation and Cardiovascular Disease. The microcirculation in hypertension: a new target for treatment // Circulation. 2001. № 104. Р. 736–741.

8. Luboshitzky R., Herer P. Cardiovascular risk factors in middleaged women with subclinical hypothyroidism // Neuro Endocrinol. Lett. 2004. Vol. 25, № 4. Р. 262–6.

9. Matsukawa T., Mano T., Ishii M. Elevated sympathetic nerve activity in patients with accelerated essential hypertension // J. Clin. Invest. 1993. № 92. Р. 25–8.

10. McNeill A.M., Rosamond W.D., Girman C.J. et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study // Diabetes Care. 2005. Vol. 28, № 2. Р. 385–390.

11. Miller M.J., Pan C., Barzel U.S. The prevalence of subclinical hypothyroidism in adults with low-normal blood thyroxine levels // U.S.J. Med. 1990. Vol. 90, № 11. P. 541–544.

12. Rodondi N., Aujesky D., Vittinghoff E. et al. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis // Am. J. Med. 2006. № 119. Р. 541–551.

13. Rodondi N., Bauer D.C., Cappola A. R., Cornuz J. et al. Subclinical Thyroid Dysfunction, Cardiac Function, and the Risk of Heart Failure. The Cardiovascular Health Study // J. Am. Coll. Cardiol. 2008. № 52. Р. 1152–1159.

14. Rodondi N., Newman A., Vittinghoff E. et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death // Arch. Intern. Med. 2005. № 165. Р. 2460–2466.

15. Staub J.J., Althaus B.U., Engler H. et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues // Am. J. Med. 1992. Vol. 92, № 6. P. 631–642.

16. Tunbridge W.M.G., Evered D.C., Hall R. et al. The spectrum of thyroid disease in a community: The Whickham survey // Clin. Endocrinol. 1997. Vol. 7. P. 481–493.

17. Walsh J.P., Bremner A.P. et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease // Arch. Intern. Med. 2005. № 165. Р. 2467–72.

18. Wang C., Crapo L. The epidemiology of thyroid disease and implication for screening // Endocrinol. Metab. Clin. N. Amer. 1997. Vol. 26. P. 189–218.

19. Weidmann P., de Courten M., Bohlen L. Insulin resistance, hyperinsulinaemia and hypertension // J. Hypertens. 1993. № 11 (Suppl. 5). Р. 27–38.